Biocon Biologics LimitedAugust 26, 2022

FDA 483 - Biocon Biologics Limited - August 26, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This 483 record concerns Biocon Biologics Limited, with an inspection on August 26, 2022, issued by the Office of Biological Products Operations - Division I, covering drugs.

Company: Biocon Biologics Limited
Inspection Date: August 26, 2022
Product Type: Drugs
Office: Office of Biological Products Operations - Division I
People: Zheng Liang (Legal Representative/ General Manager)
Arsen Karapetyan
Ralph M. Bernstein
Michael R. Shanks (Investigator)

Open in Dashboard

ID · 389806fd-0ee4-4841-b19c-fe0c775d7c7b